General Information
Aripiprazole is a quinoline derivate and atypical antipsychotic agent. Aripiprazole is indicated for managing symptoms of schizophrenia and of acute manic and mixed episodes associated with bipolar I disorders in adults.
Aripiprazole has partial agonistic activity at dopamine D2 receptors and serotonin 5-HT1A receptors, as well as potent antagonistic activity on serotonin 5-HT2A receptors. Aripiprazole stabilizes dopamine and serotonin activity in the limbic and cortical system.
About the API
Technology
Synthetic Organic Chemistry
Molecular Formula
C23H27Cl2N3O2
Therapeutic category
Neurology-Psychiatry
Available formulations
Oral Liquid
Oral Solid
Regulations
CEP
EU DMF
Japan DMF
Other
US DMF
CEP
EU DMF
Japan DMF
Other
US DMF
